AJM onlineClinical communication to the EditorVascular Endothelial Growth Factor in Systemic Capillary Leak Syndrome
Clinical communication to the Editor
References (10)
- et al.
Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment
Am J Med
(1997) - et al.
Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury
Lancet
(1985) - et al.
Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines
Blood
(2004) - et al.
Cyclical edema and shock due to increased capillary permeability
Trans Assoc Am Physicians
(1960) - et al.
Chronic systemic capillary leak syndromeReport of a case and review of the literature
J Intern Med
(2000)
There are more references available in the full text version of this article.
Cited by (0)
Funding: The academic departments. Bevacizumab was provided without charge by Roche.
Conflict of Interest: Dr Punt declares that he has received fees as a member of the advisory board of Roche, manufacturer of bevacizumab. None of the other authors have any conflicts of interest associated with the work presented in this manuscript.
Authorship: All authors had access to the data and played a role in writing this manuscript.
Copyright © 2009 Elsevier Inc. All rights reserved.